We AI-mpower Ophthalmologists
We Provide You with AI Superpowers to Achieve Best-in-Class Outcomes
Empowering Your Practice
With deepeye, embark on a journey towards significantly enhanced treatment outcomes. Experience a seamless workflow, enriched with precise analysis of 3D retinal scans (OCTs), enabling more informed decisions in retinal therapy, particularly through intravitreal injections (IVI) utilizing anti-VEGF inhibitors. Your path towards optimized patient care begins here.
Benefiting Your Patients
deepeye isn't just a tool, it's a commitment towards improving the lives of individuals afflicted with retinal diseases. With our AI-driven prognostics, prepare your patients for a better tomorrow, armed with a proactive treatment plan, reducing the treatment burden and fostering a future with clearer vision.
Clinical Outcome Enhancement
More than just data, deepeye delivers actionable insights, aiding in robust treatment planning that overcome the limitations of conventional treatment regimen like T&E, PRN, IVAN, and CATT. Our pursuit of algorithmic refinement aims to redefine the treatment narrative for retinal diseases towards a (patient) need-based "predict & treat" (P&T).
Why do we think it is possible to improve upon the current state-of-the-art?
Real-world studies show that anti-VEGF therapy outcomes can be improved:
Therapy persistence from 38% to 78% = 2x more patients remaining in therapy after 24 months
"Intravitreal therapy cannot work if you do not receive them and appear at follow-up visits."
B. Sobolewska et al.
Reach out to our Regulatory Affairs Team
We value your feedback and understand that you may have questions or concerns regarding our medical device software products (not yet available for clinical use). Our Regulatory Affairs team is here to assist you. Whether you have a product complaint, a suggestion, or just need more information, we are happy to help. Your input is important to us and helps us continually improve our products and services.